Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey-Reference-Cited by-同舟云学术

Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey

Published:2018-06-05 Issue:4 Volume:24 Page:e266-e268
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Peyvandi F.¹²^ORCID,Palla R.¹^ORCID,Franchi C.³,Nobili A.³,Rosendaal F. R.⁴,Mannucci P. M.¹²

Affiliation:

1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Luigi Villa Foundation; Milan Italy

2. Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan Italy

3. Department of Neuroscience; IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”; Milan Italy

4. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden The Netherlands

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13535/fullpdf

Reference10 articles.

1. A randomized trial of factor VIII and neutralizing antibodies in hemophilia A;Peyvandi;N Engl J Med,2016

2. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review;Iorio;J Thromb Haemost,2010

3. Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis;Marcucci;Thromb Haemost,2015

4. Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates;Kempton;J Thromb Haemost,2006

5. Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression;Xi;J Thromb Haemost,2013